Quorum Quenching: The New Frontier in Acne
Cosmetic testing for acne is shifting from simply killing bacteria to influencing their communication. A new approach called Quorum Quenching Analysis investigates how ingredients can disrupt bacterial signals linked to problematic behaviours like biofilm formation.

The science behind testing anti-acne cosmetics is undergoing a significant shift. Research is moving beyond simply measuring bacterial reduction to explore how to influence microbial behaviour and communication, according to a report from cosmetics testing leader QACS.
This evolution is driven by a deeper understanding of Cutibacterium acnes. While C. acnes is a normal part of the skin's microbiome, its mere presence does not cause acne. Scientists now point to differences between bacterial strains, overall microbial diversity, and complex interactions within the skin's ecosystem as key factors.
From Killing Bacteria to Changing Behaviour
Traditional antimicrobial testing for cosmetics checks if a formulation reduces bacterial growth or viability. That approach has limits. It does not explain how microorganisms communicate or act as coordinated communities.
One critical behaviour is biofilm formation. Bacteria can create structured, protected communities. Research into acne increasingly considers this biofilm-associated activity as part of the condition's complex microbiology. For cosmetic developers, this means an opportunity. The focus can expand from eliminating C. acnes to investigating whether specific microbial behaviours can be influenced.
The Role of Quorum Sensing and Quenching
Quorum Sensing is a bacterial communication system. Microorganisms use signalling molecules to coordinate community-level behaviours. These can include functions linked to biofilm formation.
Quorum Quenching refers to methods that interfere with these communication processes. For cosmetic research, this offers an alternative to broad-spectrum antimicrobial strategies. It allows scientists to explore if an ingredient can influence bacterial talk and related actions without solely relying on killing the bacteria.
Recent academic work supports this direction. A 2026 study by Kupke et al. examined C. acnes and Staphylococcus epidermidis in mixed systems. The research looked at their interactions, quorum-sensing activity, biofilm traits, and the potential quorum-sensing inhibitory effects of an extract from Plectranthus aliciae. Such findings highlight growing scientific interest in the field.
A New Testing Tool for Developers
QACS has developed Quorum Quenching Analysis (QQA) as a new laboratory tool. This in vitro method investigates the potential of cosmetic ingredients and formulations to interfere with bacterial communication under controlled conditions.
For brands, QQA can complement existing tests like those for C. acnes, antimicrobial activity, biofilm formation, and general microbiome impact. This allows for a multi-faceted evaluation of a formulation's microbiological profile instead of relying on a single result.
The analysis can be part of an early-stage screening strategy for candidate ingredients. It helps identify those with promising quorum-quenching activity for further development. The value lies not just in seeing if bacteria are reduced, but in exploring how their behaviour might be changed.
The future of testing for acne-prone skin products involves a more nuanced view of the microbial ecosystem. It is less about indiscriminate elimination and more about understanding balance and interactions. QACS states it supports brands in translating this emerging microbiome science into practical lab strategies. This helps build stronger scientific foundations for product development.





